Julie Henriques

1.7k total citations · 1 hit paper
61 papers, 812 citations indexed

About

Julie Henriques is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Julie Henriques has authored 61 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Julie Henriques's work include Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (15 papers) and Genetic factors in colorectal cancer (9 papers). Julie Henriques is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (15 papers) and Genetic factors in colorectal cancer (9 papers). Julie Henriques collaborates with scholars based in France, United States and Italy. Julie Henriques's co-authors include Christophe Louvet, Thierry André, Juan‐Pablo Ortega, Lyudmila Grigoryeva, Magali Svrcek, Déwi Vernerey, Jérôme Desrame, Romain Cohen, David Tougeron and Laurent Larger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Julie Henriques

57 papers receiving 806 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

2022 220 citations Thierry André, David Tougeron et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Julie Henriques

Since Specialization

Citations

This map shows the geographic impact of Julie Henriques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Henriques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Henriques more than expected).

Fields of papers citing papers by Julie Henriques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Henriques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Henriques. The network helps show where Julie Henriques may publish in the future.

Co-authorship network of co-authors of Julie Henriques

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Henriques. A scholar is included among the top collaborators of Julie Henriques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Henriques. Julie Henriques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity 2025 ·Journal of Cachexia Sarcopenia and Muscle ·(unknown), F. Pigneur, Marc Hilmi, (unknown), (unknown), Dewi Vernerey, Alain Luciani, Pascal Hammel, Julie Henriques, (unknown), Anthony Turpin	2
2	Characterization and clinical outcomes of rare biliary adenosquamous carcinoma 2025 ·European Journal of Surgical Oncology ·(unknown), Franck Monnien, (unknown), Julie Henriques, Francine Fein, Alexandre Doussot, Lucine Vuitton, Christophe Borg, Angélique Vienot	2
3	Nutritional intervention with adapted physical activity (APA) in patients (PTS) with advanced pancreatic cancer (NUTAPACAP): An ancillary of the apacap gercor randomized controlled trial 2024 ·Clinical Nutrition ESPEN ·(unknown), Susana Pereira, (unknown), (unknown), Déwi Vernerey, Julie Henriques, Victoire Cardot‐Ruffino, Pascal Hammel, Cindy Neuzillet	0
4	Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial 2023 ·Journal of the National Comprehensive Cancer Network ·Cindy Neuzillet, Olivier Bouché, Christophe Tournigand, Benoist Chibaudel, (unknown), Leïla Bengrine-Lefèvre, (unknown), May Mabro, Jean‐Philippe Metges, Denis Péré-Vergé, Thierry Conroy, Astrid Lièvre, (unknown), Françoise Desseigne, François Goldwasser, Julie Henriques, Amélie Anota, Pascal Hammel	13
5	119P Management of biliary tract cancers in older patients: A French multicenter cohort study 2023 ·Annals of Oncology ·(unknown), Julien Edeline, Julie Henriques, (unknown), Héloïse Bourien, (unknown), Nadim Farés, Christophe Tournigand, Thierry Lecomte, David Tougeron, Vincent Hautefeuille, Angélique Vienot, Nicolas Williet, (unknown), David Malka, Cristina Smolenschi, Antoine Hollebecque, (unknown), Anthony Turpin, Alice Boilève	1
6	P-281 Safety analysis and preliminary clinical results of REPROGRAM-01 phase II study evaluating regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer 2023 ·Annals of Oncology ·Christophe Borg, (unknown), (unknown), François Ghiringhelli, Stéfano Kim, Déwi Vernerey, Julie Henriques, Trang Huyen Thi Nguyen, Aurélia Meurisse, Serge Fratté, (unknown), Laurie Spehner, (unknown), Angélique Vienot	0
7	650P Genomic profiling of small bowel adenocarcinoma: A pooled analysis 2023 ·Annals of Oncology ·Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfrédi, (unknown), David Tougeron, (unknown), Denis Pezet, Éric Terrebonne, Guillaume Piessen, Pauline Afchain, C. Lécaille, Marc Pocard, Thierry Lecomte, Valentina Burgio, F. Di Fiore, Stefano Cascinu, Déwi Vernerey, Pierre Laurent‐Puig	2
8	Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study breakdown → 2022 ·Journal of Clinical Oncology ·Thierry André, David Tougeron, Guillaume Piessen, Christelle de la Fouchardière, Christophe Louvet, Antoine Adenis, Marine Jary, Christophe Tournigand, Thomas Aparicio, Jérôme Desrame, Astrid Lièvre, Marie‐Line Garcia‐Larnicol, T. Pudlarz, Romain Cohen, (unknown), Dewi Vernerey, Julie Henriques, Jérémie H. Lefèvre, Magali Svrcek	220
9	Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients 2022 ·Frontiers in Oncology ·(unknown), Julie Henriques, Déwi Vernerey, Hamadi Almotlak, Fabien Calcagno, Francine Fein, Serge Fratté, Marine Jary, (unknown), Angélique Vienot, Christophe Borg, Stéfano Kim	1
10	Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study 2022 ·European Journal of Cancer ·Benoı̂t Rousseau, (unknown), Julie Henriques, Romain Cohen, Olivier Lucidarme, Christophe Borg, Christophe Tournigand, Stéfano Kim, Jean‐Baptiste Bachet, Thibault Mazard, Christophe Louvet, Benoist Chibaudel, Déwi Vernerey, Thierry André, Anne Hulin	7
11	Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial 2021 ·Clinical Cancer Research ·Julien Taı̈eb, Valérie Taly, Julie Henriques, (unknown), Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Christophe Louvet, Céline Lepère, May Mabro, Joëlle Egreteau, Olivier Bouché, Claire Mulot, (unknown), Kariman Chaba, Thibault Mazard, Aimery de Gramont, Déwi Vernerey, Thierry André, Pierre Laurent‐Puig	71
12	Exposure‐response analysis of Raltitrexed assessing liver toxicity 2020 ·British Journal of Clinical Pharmacology ·Bernard Royer, Antonin Schmitt, Thierry Nguyen, (unknown), Marine Jary, Martin Demarchi, Déwi Vernerey, Julie Henriques, Marion Jacquin, Christophe Borg, Stéfano Kim	4
13	Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin 2020 ·JNCI Journal of the National Cancer Institute ·Aziz Zaanan, Julie Henriques, Romain Cohen, David Sefrioui, Camille Evrard, Christelle de la Fouchardière, Thierry Lecomte, Thomas Aparicio, Magali Svrcek, Julien Taı̈eb, Thierry André, Déwi Vernerey, David Tougeron	5
14	High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer 2019 ·Cellular Oncology ·Aziz Zaanan, Claire Calmel, Julie Henriques, Magali Svrcek, Hélène Blons, Christèle Desbois‐Mouthon, Fatiha Merabtene, Claire Goumard, Yann Parc, Brice Gayet, Julien Taı̈eb, Pierre Validire, Christophe Louvet, Jean–François Fléjou, Yves Le Bouc, Françoise Praz	2
15	Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab 2018 ·The Breast ·(unknown), Sophie Paget‐Bailly, P. Fumoleau, Gilles Romieu, Jean‐Yves Pierga, Marc Espié, Alain Lortholary, J.-M. Nabholtz, (unknown), Iris Pauporté, Julie Henriques, Xavier Pivot	8
16	O-012 Prognosis of lung metastases in patients with metastatic colorectal cancer: an ARCAD meta analysis 2016 ·Annals of Oncology ·Julie Henriques, Déwi Vernerey, Aimery de Gramont, Benoist Chibaudel, Eric Van Cutsem, Alfredo Falcone, Richard M. Goldberg, Qian Shi, Franck Bonnetain, Einat Shmueli	2
17	Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes 2016 ·Annals of Oncology ·Elsa Curtit, Xavier Pivot, Julie Henriques, Sophie Paget‐Bailly, P. Fumoleau, María Rios, Hervé Bonnefoi, P Soulié, Christelle Jouannaud, Hugues Bourgeois, J-Y Pierga, Isabelle Tennevet, V. Trillet-Lenoir, Pierre Kerbrat, Thomas Petit, Thomas Bachelot, J.-F. Deleuze, Iris Pauporté, Gilles Romieu, David G. Cox	3
18	Substitute or complement? Defining the relative place of EEG and fMRI in the detection of voluntary brain reactions 2015 ·Neuroscience ·Damien Gabriel, Julie Henriques, Alexandre Comte, Lyudmila Grigoryeva, Juan‐Pablo Ortega, (unknown), (unknown), Émmanuel Haffen, Thierry Moulin, Régis Aubry, Lionel Pazart	10
19	Construction, management, and performance of sparse Markowitz portfolios 2013 ·Studies in Nonlinear Dynamics and Econometrics ·Julie Henriques, Juan‐Pablo Ortega	3
20	Comparison of Methods to Correct Survival Estimates and Survival Regression Analysis on a Large HIV African Cohort 2012 ·PLoS ONE ·Julie Henriques, Mar Pujades‐Rodríguez, Megan McGuire, Elisabeth Szumilin, Jean Iwaz, Jean-François Étard, René Écochard	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact